Sanara MedTech (SMTI) Gross Margin (2010 - 2026)
Sanara MedTech's (SMTI) quarterly Gross Margin came in at 93.08% in Q1 2026, up 91.0% YoY from 48.73% in Q1 2025, and little changed on a QoQ basis from 93.19% in Q4 2025.
Sanara MedTech (SMTI) Gross Margin (2010 - 2026) Analysis & Trends
Sanara MedTech (SMTI) has 16 years of Gross Margin data on file, last reported at 93.08% in Q1 2026.
- Quarterly Gross Margin rose 91.0% year-over-year to 93.08% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 92.92% (up 175.0% YoY) and the FY2025 annual result came in at 92.71%, up 210.0% from the prior year.
- Gross Margin was little changed at 93.08% in Q1 2026, from 93.19% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 93.19% in Q4 2025 to a low of 82.92% in Q3 2022.
- A 5-year average of 89.68% and a median of 90.04% in 2024 frame the typical range for Gross Margin.
- Annual changes were most pronounced in 2022 — Gross Margin plunged 820 bps — and 2023, when it jumped 616 bps.
- Tracing SMTI's Gross Margin over 5 years: stood at 84.53% in 2022, then grew by 6 bps to 89.89% in 2023, then rose by 2 bps to 91.45% in 2024, then grew by 2 bps to 93.19% in 2025, then dropped by 0 bps to 93.08% in 2026.
- The last three Gross Margin figures came in at 93.08% (Q1 2026), 93.19% (Q4 2025), and 92.88% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 67.78% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 46.46% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 59.33% |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 58.84% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 28.82% |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 37.74% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 58.22% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 68.00% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 34.86% |
| 10 | Sanara MedTech | 297.82 Mn | 297.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 93.08% |
| Dec 31, 2025 | 93.19% |
| Sep 30, 2025 | 92.88% |
| Jun 30, 2025 | 92.50% |
| Mar 31, 2025 | 92.17% |
| Dec 31, 2024 | 91.45% |
| Sep 30, 2024 | 90.81% |
| Jun 30, 2024 | 90.04% |
| Mar 31, 2024 | 89.80% |
| Dec 31, 2023 | 89.89% |
| Sep 30, 2023 | 89.07% |
| Jun 30, 2023 | 86.11% |
| Mar 31, 2023 | 86.31% |
| Dec 31, 2022 | 84.53% |
| Sep 30, 2022 | 82.92% |
| Jun 30, 2022 | 90.09% |
| Mar 31, 2022 | 89.69% |
| Dec 31, 2021 | 88.87% |
| Sep 30, 2021 | 91.11% |
| Jun 30, 2021 | 91.45% |